Everything below concerns bioregulator. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-05-30. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory-grade epitalon is typically supplied as a lyophilized powder. Purity is commonly assessed with reverse-phase high-performance liquid chromatography, often paired with mass spectrometry to confirm molecular identity. Amino acid analysis and peptide mapping can provide additional confirmation of sequence. Certificates of analysis for research materials frequently report purity above 95 percent, although the methods behind such figures vary between suppliers. The absence of a pharmacopeial monograph means that no single standardized assay defines the compound, so reported results depend on the analytical protocol chosen.
Storage recommendations center on limiting moisture, heat, and light. The dry powder is generally kept at minus 20 degrees Celsius, and some suppliers recommend minus 80 degrees for long-term archival. Once dissolved, solutions are usually aliquoted and frozen to avoid repeated freeze-thaw cycles, which can promote aggregation or degradation. Aqueous stability depends on pH and concentration, and buffered saline is often preferred over plain water for biological work. Stability data specific to epitalon remain limited, so general peptide-handling practices are applied by analogy rather than from product-specific validation.
The most frequently cited laboratory finding is that AEDG increased telomerase activity and extended telomere length in cultured human somatic cells. That work used fetal fibroblast strains and reported changes in enzyme activity alongside altered division counts. Replication by unrelated groups has been limited, and the published record is largely a single-laboratory series rather than a multi-centre programme. The result supports a hypothesis about peptide influence on gene expression in cell culture; it does not by itself establish an effect on telomere length in living animals or in people.
Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.
No national medicines regulator has approved epitalon as a therapeutic product. It is generally distributed as a research chemical, and in some jurisdictions selling peptides for human consumption without approval is restricted or prohibited. Certificates of analysis accompanying commercial material vary in which tests are performed, and independent verification of identity and purity is uncommon. Statements about anti-ageing or disease-prevention benefits on vendor pages are marketing claims rather than regulatory findings, a distinction that shapes how the compound is discussed in scientific and popular sources alike.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C14H22N4O9 | Free acid form of the tetrapeptide |
| Molecular mass | About 390.35 Da | Calculated monoisotopic value |
| Appearance | White to off-white powder | Typical lyophilized presentation |
| Solubility | Soluble in water | Also dissolves in buffered saline |
| Storage temperature | Minus 20 degrees Celsius | Dry, dark conditions; avoid repeated thawing |
The four residues give epitalon a molecular formula of C14H22N4O9 and a molecular weight near 390.35 daltons. The presence of two acidic residues, glutamate and aspartate, makes the free peptide strongly acidic, while the alanine and glycine ends provide neutral, nonpolar character. This combination produces a molecule with substantial water solubility. Because there are no cysteine, methionine, or tryptophan residues, the peptide lacks the most common oxidation-sensitive side chains, which simplifies handling compared with many longer peptides.
The proposed relationship between epitalon and pineal function is a central part of its background. Khavinson's group reported that short peptides corresponding to regions of larger pineal proteins could influence gene expression in cells. Epitalon was framed as a synthetic analogue of an active fragment rather than a direct isolation product. Whether the tetrapeptide reproduces the effects of the parent extract is an open question, because comparative studies are limited and the parent extract itself is not a single defined substance.
Interest in epitalon is usually discussed within the broader field of short peptide bioregulators, a category that includes other synthetic di-, tri-, and tetrapeptides studied by the same research group. These compounds share a common rationale: that small fragments of tissue-derived proteins can retain biological activity and can be produced reproducibly. The category as a whole remains outside mainstream pharmacological consensus, and epitalon specifically has a limited presence in independent, non-Russian research literature, which shapes how its evidence base is described.
Stability depends strongly on pH, temperature and the presence of oxygen and trace metals. Cleavage of the backbone proceeds faster under neutral to alkaline conditions, whereas acidic solutions tend to slow that reaction. The aspartate and glutamate side chains can undergo deamidation or imide formation over time, generating closely related impurities. Published stability data specific to epitalon are sparse, so the usable life of a given solution is best regarded as an open question that depends on buffer composition, concentration and storage temperature.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography with ultraviolet detection, frequently near 214 nanometers where the peptide bond absorbs. Mass spectrometry, most often with electrospray ionization, confirms the observed molecular mass and helps separate the intact peptide from truncated or modified forms. Amino acid analysis or tandem mass spectrometry can establish residue order. Purity is commonly quoted as an area percentage, yet such values are method-dependent, and comparisons between laboratories require matching column, gradient and detection wavelength.
By 1986, the task force had made over 15,000 arrests and seized over six million pounds of cannabis and 100,000 pounds of cocaine, doubling cocaine seizures annually – administration officials called it Reagan's biggest drug enforcement success. However, law enforcement agents at the time said their impact was minimal; cocaine imports had increased by 10%, to an estimated 75–80% of America's supply. According to the head of the task force's investigative unit, "Law enforcement just can't stop the drugs from coming in." A Bush spokesperson emphasized disrupting smuggling routes rather than seizure quantities as the measure of success." In 1984, Reagan signed the Comprehensive Crime Control Act, which included harsher penalties for cannabis cultivation, possession, and distribution. It also established equitable sharing, a new civil asset forfeiture program that allowed state and local law enforcement to share the proceeds from asset seizures made in collaboration with federal agencies. Under the controversial program, up to 80% of seizure proceeds can go to local law enforcement, expanding their budgets. By 2019, $36.5 billion worth of assets had been seized, much of it drug-related, much of it distributed to state and local agencies.
At the same time, the Central Intelligence Agency (CIA) was accused of facilitating the drug trade in Mexico and elsewhere to fund anticommunist guerilla forces in Central and South America. A number of former DEA agents, CIA agents, Mexican police officers, and historians contend that the CIA was complicit in the murder of DEA agent Kiki Camarena, who discovered and attempted to reveal the CIA's role in the drug trade. Between 2013 and 2015, the Mexican newspaper Proceso, journalist Jesús Esquivel, journalists Charles Bowden and Molly Malloy, and historians Russell and Silvia Bartley published investigative reports and books making the same allegation. They wrote that Camarena, like Mexican journalist Manuel Buendía, discovered that the CIA helped organize drug trafficking from Mexico into the United States to fund the anti-communist Contras in Nicaragua as a part of the Cold War. Historian Wil Pansters explained that US victory in the Cold War was more important to the CIA than the DEA's war on drugs:Since the overriding concern of the CIA was the anti-Sandinista project, it trumped the DEA's task of combating drug trafficking, and covertly incorporated (or pressured) parts of the Mexican state into subservience. Buendía had found out about the CIA-contra-drugs-DFS connection, which seriously questioned Mexican sovereignty, while Camarena learned that the CIA had infiltrated the DEA and sabotaged its work so as to interfere with the clandestine contra-DFS-traffickers network. They knew too much and were eliminated on the orders of the U.S. with Mexican complicity.
Later official investigations attempted to limit criminal responsibility to the dirty connections between drug traffickers, secret agents and corrupt police, leaving out the (geo)political ramifications. The CIA has denied allegations of involvement in killing Camarena. Historian Benjamin T. Smith said the allegations have "...holes. Big holes." He also calls Russell and Silvia Bartley's investigation "occasionally paranoid" and notes the fact that "Many-including some members of the DEA" dismiss one of the key sources for this (i.e. Lawrence Victor Harrison) as a "crank". However Smith also acknowledged the fact that the case is a "deep, dark hole....[where] Fiction and reality are firmly intertwined."
Sources: en.wikipedia.org
==== Crackdown on crack ==== As the media focused on the emergence of crack cocaine in the early 1980s, the Reagan administration shored up negative public opinion, encouraging the DEA to emphasize the harmful effects of the drug. Stories of "crack whores" and "crack babies" became commonplace. In mid-1986, crack dominated the news. Time declared crack the issue of the year. Newsweek compared the magnitude of the crack story to Vietnam and Watergate. The cocaine overdose deaths of rising basketball star Len Bias, and young NFL football player Don Rogers, both in June, received wide coverage. Riding the wave of public fervor, that October Reagan signed into law much harsher sentencing for crack through the Anti-Drug Abuse Act, commonly known as the Len Bias law. According to historian Elizabeth Hinton, "[Reagan] led Congress in criminalizing drug users, especially African American drug users, by concentrating and stiffening penalties for the possession of the crystalline rock form of cocaine, known as 'crack', rather than the crystallized methamphetamine that White House officials recognized was as much of a problem among low-income white Americans". The Anti-Drug Abuse Act appropriated an additional $1.7 billion to drug war funding, and established 29 new mandatory minimum sentences for drug offenses (until then, the American legal system had seen 55 minimum sentences in total). Of particular note, the act made sentences for larger amounts of cocaine 100 times more severe for crack than for the powder form.
Sources: en.wikipedia.org
Epitalon is a synthetic tetrapeptide built from four amino acids: alanine, glutamate, aspartate, and glycine. It is not extracted from a natural source but made in the laboratory by chemical synthesis. Its short length makes it relatively straightforward to produce at high purity.
No naturally occurring free form of the peptide has been described. The four-amino-acid sequence can appear as a fragment within larger proteins, but that is not the same as the intact compound being present as a circulating molecule. Materials used in research are synthetic.
Purity is usually checked by reverse-phase high-performance liquid chromatography, which separates the target peptide from related impurities. Mass spectrometry is commonly used alongside it to confirm molecular mass. Some suppliers also provide amino acid analysis for additional sequence confirmation.
Small studies with human participants have been reported, chiefly in Russian-language journals, but they are limited in size and design. No large randomised controlled trial with published results is available.